iBio Inc.
IBIO | NASDAQ
$1.29
+$0.03 (+2.38%)
Sep 22, 2026, 1:35 PM ET · Market open
TTM Period Ending | Q4 2026 Jun 29, 2026 | Q3 2026 Mar 30, 2026 | Q2 2026 Dec 30, 2025 | Q1 2026 Sep 29, 2025 | Q4 2025 Jun 29, 2025 | Q3 2025 Mar 30, 2025 | Q2 2025 Dec 30, 2024 | Q1 2025 Sep 29, 2024 | Q4 2024 Jun 29, 2024 | Q3 2024 Mar 30, 2024 | Q2 2024 Dec 30, 2023 | Q1 2024 Sep 29, 2023 | Q4 2023 Jun 29, 2023 | Q3 2023 Mar 30, 2023 | Q2 2023 Dec 30, 2022 | Q1 2023 Sep 29, 2022 | Q4 2022 Jun 29, 2022 | Q3 2022 Mar 30, 2022 | Q2 2022 Dec 30, 2021 | Q1 2022 Sep 29, 2021 | Q4 2021 Jun 29, 2021 | Q3 2021 Mar 30, 2021 | Q2 2021 Dec 30, 2020 | Q1 2021 Sep 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 100K | 300K | 300K | 500K | 400K | 375K | 375K | 175K | 225K | 50K | 50K | 50K | n/a | 61K | 1.86M | 1.86M | 1.95M | 2.38M | 1.34M | 2.05M | 2.37M | 3M | 2.33M | 1.94M |
Cost of Revenue | n/a | 780K | 530K | 289K | n/a | 281K | 281K | 281K | 531K | 281K | 563K | 563K | 313K | 297K | 15K | 1.05M | 1.86M | 2.03M | 2.52M | 1.7M | 998K | 1.67M | 1.27M | 1.06M |
Gross Profit | 100K | -480K | -230K | 211K | 400K | 94K | 94K | -106K | -306K | -231K | -513K | -513K | -313K | -236K | 1.85M | 813K | 87K | 345K | -1.18M | 344K | 1.37M | 1.33M | 1.07M | 885K |
Operating Income | -35.14M | -23.96M | -22.97M | -20.45M | -18.6M | -16.81M | -15.56M | -15.64M | -16.63M | -18.19M | -20.73M | -26.81M | -29.34M | -41.27M | -41.89M | -38.55M | -36.14M | -28.68M | -29.1M | -29.41M | -31.11M | -24.6M | -21.46M | -17.07M |
Interest Income | 2.15M | 1.5M | 911K | 530K | 437K | 581K | 552K | 482K | 363K | 190K | 170K | 169K | 213K | 230K | 247K | 241K | 178K | 68K | 180K | 172K | 140K | 186K | 38K | 15K |
Pretax Income | -33.04M | -27.61M | -24.74M | -20.11M | -18.38M | -16.46M | -14.23M | -14.36M | -15.44M | -17.13M | -20.77M | -26.85M | -29.31M | -41.43M | -41.9M | -38.53M | -36.18M | -19.01M | -19.93M | -20.87M | -23.21M | -26.87M | -23.88M | -19.51M |
Net Income | -33.04M | -27.61M | -24.74M | -20.11M | -18.38M | -20.99M | -19.3M | -23.15M | -24.91M | -23.16M | -27.28M | -52.63M | -65.01M | -76.03M | -81.13M | -59.49M | -50.3M | -33.13M | -28.4M | -24.61M | -23.21M | -26.86M | -23.88M | -19.51M |
Selling & General & Admin | 10.6M | 14.95M | 12.81M | 10.39M | 10.69M | 10.68M | 10.43M | 10.65M | 11.14M | 11.56M | 12.08M | 16.91M | 18.7M | 26.73M | 28.8M | 25.35M | 23.63M | 19.67M | 19.66M | 20.99M | 22.99M | 18.95M | 16.61M | 13.53M |
Research & Development | 19.64M | 14.31M | 12.96M | 10.56M | 8.31M | 6.23M | 5.23M | 4.88M | 5.19M | 6.4M | 8.14M | 9.39M | 10.33M | 14.31M | 14.94M | 14.02M | 12.6M | 9.36M | 8.25M | 8.77M | 9.5M | 6.98M | 5.91M | 4.43M |
Other Expenses | 5M | -5.78M | -3.03M | -289K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K |
Operating Expenses | 35.24M | 23.48M | 22.74M | 20.66M | 19M | 16.91M | 15.65M | 15.53M | 16.33M | 17.96M | 20.22M | 26.3M | 29.03M | 41.04M | 43.74M | 39.36M | 36.23M | 29.03M | 27.92M | 29.76M | 32.48M | 25.93M | 22.53M | 17.96M |
Interest Expense | 53K | 143K | 175K | 191K | 212K | 228K | 226K | 203K | 172K | 129K | 112K | 109K | 83K | 291K | 256K | 225K | 834K | 1.22M | 1.83M | 2.45M | 2.45M | 2.46M | 2.46M | 2.46M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 35.24M | 24.26M | 23.27M | 20.95M | 19M | 17.19M | 15.94M | 15.81M | 16.86M | 18.24M | 20.78M | 26.86M | 29.34M | 41.34M | 43.75M | 40.41M | 38.09M | 31.06M | 30.44M | 31.46M | 33.48M | 27.6M | 23.79M | 19.01M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 104.06M | 119.6M | 99.13M | 52.98M | 16.42M | 9.86M | 9.13M | 8.63M | 8.62M | 3.71M | 1.86M | 1.2M | 1.02M | 659.2K | 490.35K | 442.1K | 17.45K | 435.95K | 435.98K | 435.75K | 435.75K | 431.08K | 376.17K | 324.88K |
Shares Outstanding (Diluted) | 104.06M | 119.6M | 99.13M | 52.98M | 16.42M | 9.86M | 9.13M | 8.63M | 8.62M | 3.71M | 1.86M | 1.2M | 1.02M | 659.2K | 490.35K | 442.1K | 17.45K | 435.95K | 435.98K | 435.75K | 435.75K | 431.08K | 376.17K | 324.88K |
EPS (Basic) | -0.33 | -0.58 | -1 | -1.39 | -1.74 | -2.33 | -2.69 | -6.63 | -10.96 | -16 | -26.21 | -90.22 | -126.44 | -1.1K | -1.11K | -1.07K | -1.05K | -76.35 | -65.85 | -60.24 | -62.97 | -75.95 | -87.69 | -409.75 |
EPS (Diluted) | -0.33 | -0.58 | -1 | -1.39 | -1.74 | -2.33 | -2.69 | -6.63 | -10.96 | -16 | -26.21 | -90.22 | -126.44 | -1.1K | -1.11K | -1.07K | -1.05K | -76.35 | -65.85 | -60.24 | -62.97 | -75.95 | -87.69 | -409.75 |
EBITDA | -32.35M | -26.4M | -23.47M | -18.78M | -17.04M | -15.11M | -12.84M | -12.95M | -14.09M | -16.07M | -19.78M | -25.88M | -28.12M | -39.11M | -38.9M | -34.83M | -32.16M | -14.93M | -15.63M | -16.39M | -18.35M | -22.06M | -19.11M | -14.79M |
EBIT | -32.99M | -27.46M | -24.56M | -19.92M | -18.17M | -16.23M | -14.01M | -14.16M | -15.27M | -17M | -20.66M | -26.74M | -29.23M | -41.14M | -41.64M | -38.3M | -35.96M | -18.4M | -18.7M | -19.03M | -20.76M | -24.41M | -21.42M | -17.05M |
Depreciation & Amortization | 646K | 1.07M | 1.1M | 1.14M | 1.13M | 1.12M | 1.17M | 1.21M | 1.18M | 932K | 882K | 862K | 1.11M | 2.03M | 2.74M | 3.47M | 3.79M | 3.47M | 3.07M | 2.64M | 2.41M | 2.35M | 2.31M | 2.27M |
Add to Watchlist
Select watchlists to add or remove IBIO